MoonRISe-1: TAR-210 for non-muscle-invasive bladder cancer

This Medudy course is a video tutorial for physicians on "MoonRISe-1: TAR-210 for non-muscle invasive bladder cancer". Despite the availability of treatment options for patients with intermediate-risk non-muscle-invasive bladder cancer, recurrence rates remain high. The Moonrise-1 trial is investigating TAR-210, an intravesical drug delivery system that enables the sustained release of erdafitinib directly into the bladder. [...]
Muscle-invasive bladder carcinoma

Prof. Dr. med. Günter Niegisch
Insulin Efsitora vs. Degludec for type 1 diabetes

This Medudy course is a video tutorial for physicians on the topic of "Insulin Efsitora vs Insulin Degludec in type 1 diabetes". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Insulin Efsitora alfa is a basal insulin that is administered once a week. The efficacy [...]
Patisiran for transthyretin amyloidosis with cardiomyopathy

This Medudy course is a video tutorial for physicians on the topic "Patisiran in transthyretin amyloidosis with cardiomyopathy". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Transthyretin amyloidosis (ATTR) is a progressive disease caused by misfolded transthyretin, which manifests as a [...]
Semaglutide for obesity and knee osteoarthritis

This Medudy course is a video tutorial for physicians on the topic of "Semaglutide in obesity and knee osteoarthritis". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Obesity is considered a major risk factor for knee osteoarthritis. Current guidelines therefore recommend weight reduction and increased physical [...]
Tapinarof cream for atopic dermatitis

This Medudy course is a video tutorial for physicians on the topic of "Tapinarof cream for atopic dermatitis". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. "Tapinarof cream 1% once daily" is a topical aryl hydrocarbon receptor agonist. It downregulates pro-inflammatory Th2 cytokines, components [...]
Suicide attempts after PCOS diagnosis

This Medudy course is a video tutorial for physicians on the topic of "Suicide attempts after PCOS diagnosis". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. People with polycystic ovary syndrome (PCOS) may be at increased risk of suicide. However, there is little evidence [...]
Combination therapy with ivonescimab for EGFR-positive NSCLC

This Medudy course is a video tutorial for physicians on the topic of "Combination therapy with ivonescimab in EGFR-positive NSCLC". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the standard first-line treatment for patients with non-small cell lung cancer (NSCLC) [...].
Diagnostic procedures for lung lesions

This Medudy course is a video tutorial for physicians on the topic of "Diagnostic procedures for pulmonary lesions", in which we summarize the latest and most important clinical studies for you. This Medudy course is a video tutorial for physicians. The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most [...]
IL-4-mediated immunotherapy resistance in ovarian cancer

This Medudy course is a video tutorial for physicians on the topic of "IL-4-mediated immunotherapy resistance in ovarian cancer". The format used here is a so-called "Journal Club Summary", in which we summarize the latest and most clinically relevant studies for you. Immune checkpoint blockade therapies have shown limited success in ovarian cancer. This therapy resistance is mediated by the immunosuppressive tumor microenvironment (TME) [...]